Top Tech Companies (2,070)
Don't see your company?
Create a company profile
Cyrcadia Health develops a breast health screening device and method based on disruptive technology and tissue health science.
Tree of Life Seeds provides products with a full spectrum Phytocannabinoid-Rich (PCR) oil.
http://www.cardia.com
Beckman Coulter is committed to advancing healthcare for every person by applying the power of science, technology, and the passion and creativity of our teams to enhance the diagnostic laboratory’s role in improving healthcare outcomes. Our diagnostic systems are used in complex biomedical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. Beckman Coulter offers a unique combination of people, processes and solutions designed to elevate the performance of clinical laboratories and healthcare networks. We do this by accelerating care with a menu that matters, bringing the benefit of automation to all, delivering greater insights through clinical informatics and unlocking hidden value through performance partnership. An operating company of Danaher Corporation since 2011, Beckman Coulter is headquartered in Brea, Calif., and has more than 11,000 global associates working diligently to make the world a healthier place.
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer.
Helping Make Research Possible We are helping make research possible by supplying scientists worldwide with the assay kits, antibodies, proteins, and biochemicals to advance their research. We know the scientific community needs more than our products, so our 100 in-house scientists, the same who design and develop our products, connect with researchers to answer questions, provide resources, and offer contract research services. We offer tools for diverse research areas, including cancer, inflammation, nitric oxide, neuroscience, epigenetics, diabetes, apoptosis, oxidative injury, endocrinology, atherosclerosis, and many more. We are also a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.
New reverse osmosis membranes are what the industry has been waiting for. Reverse osmosis has been proven to be the most efficient way to purify water. However, this process has also proven to be more expensive than what it could be. We will bring innovation to desalination by introducing these new membranes that will knock out biofouling and ultimately be more cost-efficient.
Gentueri works with laboratories to improve the quality of results and laboratory efficiency.
Atreon Orthopedics is a tissue regeneration company powered by breakthrough regenerative technology and renowned scientific expertise. Tendon and ligament injuries affect ten million people yearly, spanning all lifestyles and demographics. Atreon is committed to dramatically improving healing and long-term outcomes for patients encountering these soft-tissue injuries. ROTIUM®, our initial product for rotator cuff repair, is a bioresorbable wick designed as a scaffold to harness and hold biologically active substances at the repair site providing a pro-healing environment that promotes healthy tissue and native tissue regeneration. Recently published human and animal studies and over 3,000 cases have shown a safe and effective solution to improving biology, restoring function, and improving rotator cuff success rates.
Poseida Therapeutics is a biotechnology company that utilizes genome engineering capabilities to develop targeted life-saving therapeutics.
NX PharmaGen acquires, develops, and monetizes mature clinical-stage breakthrough technologies.
We help scientists solve disease and extend healthspan by building tools that simplify R&D, simulate biology, and untangle the complexity of life. Streamline computational analysis today. Simulate biology tomorrow.
A clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases with unmet medical needs, including neurodegenerative diseases, cancer and autoimmune disorders.
BioNumerik Pharmaceuticals discovers, develops and commercializes drugs for treating cancer.
Rare Disease Data Trust accelerates the discovery and diagnosis of targeted rare disease patients.
Hospital Corporation of America (HCA) provides healthcare services in locally managed facilities in 20 states in the U.S. and England.
Biopeptide company offers design, synthesis, and production of peptides using Fmoc solid phase and solution phase technology.
CHF Solutions is a medical device company that focuses on innovative cardiac assist therapy to treat patients.
Specializing in Microfluidic Product Development, ALine uses a rapid Design-Build-Test-Scale Cycle platform to help customers create commercially successful Microfluidics-based and Lab-on-a-Chip products. Throughout our 17 years in business, ALine’s expert engineering solutions allows our customers to move their product quickly from research and development to product transfer and large-scale manufacturing. ALine’s unique culture of scientific excellence and practical problem solving is realized in the quality and performance of every device we build. We’ve supported thousands of customers in building their microfluidic devices, let us help you!
Nabsys uses proprietary electronic nano-channel detectors to analyze long DNA molecules at high velocity. Electronic detection enables Nabsys to achieve significantly higher resolution than can be obtained using optical mapping methods. Nabsys HD-Mapping™ solid-state electronic nano-channel detectors build whole genome maps with sub-diffraction-limit resolution that are truly high definition. These maps offer compelling advantages for the analysis of structural variation, the assembly of genomes, and as a method for confirming putative variants called using other technologies. HD-Mapping works by adding sequence-specific tags to long DNA molecules. These molecules pass through the nano-detectors at high velocity using a combination of electrophoretic and hydrodynamic control. The detectors report the locations of the sequence-specific tags on the molecules. The information is then analyzed by Nabsys analytical software. Key application areas that are enabled by Nabsys include: • De Novo Assembly • Structural Variant Discovery • Variant Verification • Microbiome Analysis • Metagenome Characterization • Hybrid Assembly Nabsys provides the complete solution for electronic genome mapping. The Nabsys HD-Mapping platform includes: • HD-Mapping instrument • Electronic nano-channel detector chips • Complete run reagent cartridge • Sample prep kit • Comprehensive control and data analysis software Nabsys HD Mapping provides routine, accurate, cost-effective analysis of genomic structural information. The HD-Mapping platform employs fully electronic detection of tagged single DNA molecules to provide significantly higher sensitivity, accuracy, scalability and speed of detection in comparison to existing mapping technologies. Single-molecule reads, hundreds of kilobases in length, have high resolution and low error rates, resulting in high information content per read.
